<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00774514</url>
  </required_header>
  <id_info>
    <org_study_id>Dnr 08-113M</org_study_id>
    <nct_id>NCT00774514</nct_id>
  </id_info>
  <brief_title>The Cardiovascular Effects of Nitrogen Dioxide Exposure</brief_title>
  <official_title>The Cardiovascular Effects of Nitrogen Dioxide Exposure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exposure to air pollution has been linked to increased cardiorespiratory morbidity and
      mortality. The exact component of air pollution that mediates this effect is unknown, but the
      link is strongest for fine combustion derived particulate matter derived from traffic
      sources. It has been demonstrated that inhalation of diesel exhaust impairs vascular
      vasomotor tone and endogenous fibrinolysis. Recent studies using an inline retrofit particle
      trap to reduce the particulate component of exhaust have shown that filtering particles leads
      to a reversal of the endothelial dysfunction seen after diesel exhaust exposure, and have
      even suggested an augmentation of vascular function. This raises the question of the
      cardiovascular effects of the gaseous pollutants, the most abundant of which is nitrogen
      dioxide. In this study we plan to investigate the cardiovascular effects of nitrogen dioxide
      exposure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forearm blood flow measured by venous occlusion plethysmography in response to intraarterial vasodilators (acetylcholine, sodium nitroprusside, bradykinin and verapamil)</measure>
    <time_frame>4-6 hours after exposure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma t-PA concentrations after infusion of bradykinin</measure>
    <time_frame>During forearm study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exhaled nitric oxide</measure>
    <time_frame>4-6 hours after exposure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>Air exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour exposure to filtered air during intermittent exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NO2 exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 hour exposure to nitrogen dioxide at 4ppm during intermittent exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Forearm Vascular Study</intervention_name>
    <description>Forearm venous occlusion plethysmography to measure forearm blood flow during intrabrachial infusion of vasodilators Acetylcholine (5-20 mg/min), sodium nitroprusside (2-8 µg/min), bradykinin (100-1000 pmol/min) and verapamil (10-100 µg/min)</description>
    <arm_group_label>Air exposure</arm_group_label>
    <arm_group_label>NO2 exposure</arm_group_label>
    <other_name>ACh</other_name>
    <other_name>SNP</other_name>
    <other_name>BK</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male volunteers

        Exclusion Criteria:

          -  Current smokers

          -  Significant occupational exposure to air pollution

          -  Regular medication use

          -  Intercurrent illness
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Sandström, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Umeå University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anders Blomberg, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Umeå University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Umeå University</name>
      <address>
        <city>Umeå</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2008</study_first_submitted>
  <study_first_submitted_qc>October 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2008</study_first_posted>
  <last_update_submitted>April 8, 2009</last_update_submitted>
  <last_update_submitted_qc>April 8, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Anders Blomberg</name_title>
    <organization>Umeå University</organization>
  </responsible_party>
  <keyword>Air Pollution</keyword>
  <keyword>Nitrogen Dioxide</keyword>
  <keyword>NO2</keyword>
  <keyword>Endothelial dysfunction</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

